Lutris Pharma to Participate in Virtual Investor Conferences in January
TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ -- Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today
Source: finanznachrichten.de